AlzeCure Pharma’s Nomination Committee for the 2020 Annual General Meeting

The Nomination Committee, which has been appointed in accordance with the principles adopted by the Annual General Meeting on May 22, 2019, consists of:

  • William Gunnarsson, appointed by BFCM P/C BFCM Sweden Retail FT
  • Bo Rydlinger, appointed by FV Group AB
  • Liselotte Jansson, appointed by AlzeCure Discovery
  • Thomas Pollare (Chairman of the Board)

The Nomination Committee shall, before the Annual General Meeting 2020, prepare decisions on election and remuneration issues and, where applicable, procedural issues for the next Nomination Committee.

Shareholders who wish to submit proposals to the Nomination Committee before the Annual General Meeting on May 20, 2020, can do so by e-mail to birgitta.lundvik@alzecurepharma.com. Proposals must be submitted to the Nomination Committee before 1 March 2020.

For further information, please contact:

Thomas Pollare, Chairman of the Board, AlzeCure Pharma AB
Mobil: +46(0)70-810 79 29
Email: thomas.pollare@alzecurepharma.com